top of page
Nelson Advisors > European HealthTech & MedTech


HealthTech and MedTech M&A 2026 Valuation Multipliers
The global healthcare technology and medical technology sectors have transitioned into a definitive era of disciplined industrial maturity as of the first half of 2026. This period, characterised as the emergence of HealthTech 2.0, represents a structural shift from the speculative, volume-driven dealmaking of the pandemic era toward high-value, transformative transactions grounded in fundamental business metrics. As 2026 unfolds, the market is witnessing a selective recovery
Nelson Advisors
May 314 min read


Blackstone focuses on large scale deals across technology infrastructure and healthcare technology
Blackstone, which, as of the conclusion of 2025, has solidified its position as the preeminent architect of the physical and technological foundations of the modern economy. By managing over $1.27 Trillion in assets, the firm has pivoted away from the broad-market indexing approach of the previous decade toward a concentrated focus on high-conviction mega-trends, most notably the build-out of artificial intelligence infrastructure and the technological revolution within the l
Nelson Advisors
Feb 1215 min read
bottom of page